Country: Велика Британија
Језик: Енглески
Извор: MHRA (Medicines & Healthcare Products Regulatory Agency)
Loperamide hydrochloride
DE Pharmaceuticals
A07DA03
Loperamide hydrochloride
2mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 01040200
Package leaflet: Information for the user LOPERAMIDE 2 MG TABLETS loperamide hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What LOPERAMIDE TABLET is and What it is used for 2. What you need to know before you use LOPERAMIDE TABLETS 3. How to use LOPERAMIDE TABLETS 4. Possible side effects 5. How to store LOPERAMIDE TABLETS 6. Contents of the pack and other information 1. WHAT LOPERAMIDE TABLET IS AND WHAT IT IS USED FOR Loperamide hydrochloride is the active ingredient of Loperamide Tablets. The tablets are available in one strength. Loperamide is one of a group of medicines called "antidiarrhoeals" which are USED TO TREAT DIARRHOEA. Loperamide 2 mg tablets are used to treat sudden short-lived (acute) attacks of diarrhoea in adults and children aged 9 years and over and long-lasting (chronic) diarrhoea in adults. The tablets help reduce diarrhoea by slowing down an overactive bowel, which helps the body to absorb water and salts from this organ, making the stools more solid and less frequent. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE LOPERAMIDE TABLETS DO NOT USE LOPERAMIDE TABLETS - if you are ALLERGIC to loperamide hydrochloride or any of the other ingredients of this medicine (listed in section 6) - if you have SEVERE DIARRHOEA after taking antibiotics - if you are having a flare up of an inflammatory bowel condition like ULCERATIVE COLITIS - if you are CONSTIPATED or your STOMACH APPEARS SWOLLEN (particularly in children with severe dehydration) - if you have ACUTE DYSENTERY , the sy Прочитајте комплетан документ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Loperamide 2mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2mg loperamide hydrochloride. Excipients with known effect: each tablet contains 100mg of lactose monohydrate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Light green coloured capsule shaped, biconvex uncoated tablets, plain on one side and score line on other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the symptomatic treatment of acute diarrhoea in adults and children aged 12 years and over. For the symptomatic treatment of acute episodes of diarrhoea associated with Irritable Bowel Syndrome in adults aged 18 years and over following initial diagnosis by a doctor. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY: ACUTE DIARRHOEA Adults and children over 12: Two tablets (4 mg) initially, followed by one tablet (2 mg) after each loose stool. The usual dose is 3-4 tablets (6 mg – 8 mg) a day. The total daily dose should not exceed 6 tablets (12 mg). SYMPTOMATIC TREATMENT OF ACUTE EPISODES OF DIARRHOEA ASSOCIATED WITH IRRITABLE BOWEL SYNDROME IN ADULTS AGED 18 YEARS AND OVER Two tablets (4 mg) to be taken initially, followed by 1 tablet (2 mg) after every loose stool, or as previously advised by your doctor. The maximum daily dose should not exceed 6 tablets (12 mg). _Paediatric population_ Lopramide is contraindicated in children less than 12 years of age. _Elderly_ No dose adjustment is required for the elderly. _Renal impairment_ No dose adjustment is required for patients with renal impairment. _ _ _Hepatic impairment_ Although no pharmacokinetic data are available in patients with hepatic impairment, Lopramide should be used with caution in such patients because of reduced first pass metabolism. (see 4.4 Special warnings and special precautions for use). Method of administration Oral use. The tablets should be Прочитајте комплетан документ